ESR1 and neoplasm: Prognosis depends on the number of positive axillary nodes, tumor size, tumor grade, lymphatic and vascular invasion, expression of estrogen (ER+) and progesterone receptors, and human epidermal growth factor 2 (HER2) status (4, 5).